# Neuroblastoma Research and Treatments **Type:** Topics **Canonical URL:** https://scholariq.org/topics/neuroblastoma-research-and-treatments/ ## Facts | Field | Value | | --- | --- | | Description | This cluster of papers represents a comprehensive exploration of neuroblastoma, covering topics such as genetic mutations (including ALK and MYCN), risk classification, staging systems, immunotherapy, and genomic analysis. The research also delves into therapy strategies and prognosis for patients with neuroblastoma. | | Domain | Health Sciences | | Field | Medicine | | OpenAlex ID | t12226 | | Works | 282 | ## Topic papers all Showing 15 of 282. - [One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States](https://scholariq.org/papers/one-hundred-years-after-carcinoid-epidemiology-of-and-prognostic-factors-for/) - [Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline](https://scholariq.org/papers/management-of-immune-related-adverse-events-in-patients-treated-with-immune/) - [Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors](https://scholariq.org/papers/phase-3-trial-of-sup-177-sup-lu-dotatate-for-midgut-neuroendocrine-tumors/) - [The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report](https://scholariq.org/papers/the-international-neuroblastoma-risk-group-inrg-classification-system-an-inrg/) - [Gastroenteropancreatic neuroendocrine tumours](https://scholariq.org/papers/gastroenteropancreatic-neuroendocrine-tumours/) - [Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape](https://scholariq.org/papers/immune-inhibitory-molecules-lag-3-and-pd-1-synergistically-regulate-t-cell/) - [TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system](https://scholariq.org/papers/tnm-staging-of-foregut-neuro-endocrine-tumors-a-consensus-proposal-including-a/) - [ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors](https://scholariq.org/papers/enets-consensus-guidelines-update-for-the-management-of-patients-with-functional/) - [Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastroenteropancreatic-neuroendocrine-neoplasms-esmo-clinical-practice/) - [2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines](https://scholariq.org/papers/2000-update-of-recommendations-for-the-use-of-hematopoietic-colony-stimulating/) - [Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms](https://scholariq.org/papers/overview-of-the-2022-who-classification-of-neuroendocrine-neoplasms/) - [TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system](https://scholariq.org/papers/tnm-staging-of-midgut-and-hindgut-neuro-endocrine-tumors-a-consensus-proposal/) - [Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)](https://scholariq.org/papers/guidelines-for-the-management-of-gastroenteropancreatic-neuroendocrine-including/) - [Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma](https://scholariq.org/papers/somatic-and-germline-activating-mutations-of-the-alk-kinase-receptor-in/) - [ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary](https://scholariq.org/papers/enets-consensus-guidelines-for-the-management-of-patients-with-liver-and-other/) ## Topic primary papers Showing 15 of 56. - [The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report](https://scholariq.org/papers/the-international-neuroblastoma-risk-group-inrg-classification-system-an-inrg/) - [Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma](https://scholariq.org/papers/somatic-and-germline-activating-mutations-of-the-alk-kinase-receptor-in/) - [Synapse formation between central neurons requires postsynaptic expression of the MEN1 tumor suppressor gene.](https://scholariq.org/papers/synapse-formation-between-central-neurons-requires-postsynaptic-expression-of/) - [Comparison of RNA-seq and microarray-based models for clinical endpoint prediction](https://scholariq.org/papers/comparison-of-rna-seq-and-microarray-based-models-for-clinical-endpoint/) - [Molecular targeting therapies for neuroblastoma: Progress and challenges](https://scholariq.org/papers/molecular-targeting-therapies-for-neuroblastoma-progress-and-challenges/) - [The Neuroblastoma-Associated F1174L ALK Mutation Causes Resistance to an ALK Kinase Inhibitor in ALK-Translocated Cancers](https://scholariq.org/papers/the-neuroblastoma-associated-f1174l-alk-mutation-causes-resistance-to-an-alk/) - [Integrative genomics identifies LMO1 as a neuroblastoma oncogene](https://scholariq.org/papers/integrative-genomics-identifies-lmo1-as-a-neuroblastoma-oncogene/) - [Experimental evidence for a neural origin of Ewing's sarcoma of bone.](https://scholariq.org/papers/experimental-evidence-for-a-neural-origin-of-ewing-s-sarcoma-of-bone/) - [Deep Learning-Based Multi-Omics Data Integration Reveals Two Prognostic Subtypes in High-Risk Neuroblastoma](https://scholariq.org/papers/deep-learning-based-multi-omics-data-integration-reveals-two-prognostic-subtypes/) - [Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.](https://scholariq.org/papers/evidence-for-nm23-rna-overexpression-dna-amplification-and-mutation-in/) - [Update on neuroblastoma](https://scholariq.org/papers/update-on-neuroblastoma/) - [Neuroblastoma Cells Isolated from Bone Marrow Metastases Contain a Naturally Enriched Tumor-Initiating Cell](https://scholariq.org/papers/neuroblastoma-cells-isolated-from-bone-marrow-metastases-contain-a-naturally/) - [The epidemiology of neuroblastoma: a review](https://scholariq.org/papers/the-epidemiology-of-neuroblastoma-a-review/) - [Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004](https://scholariq.org/papers/opsoclonus-myoclonus-syndrome-in-neuroblastoma-a-report-from-a-workshop-on-the/) - [Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma](https://scholariq.org/papers/ganglioside-gd2-as-a-therapeutic-target-for-antibody-mediated-therapy-in/) --- Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.